RJ Hamster
Profit Affairs – Investing and Stock News – Profit…
Profit Affairs – Investing and Stock News – Profit Affairs – Investing and Stock News
— Read on profitaffairs.com/
RJ Hamster
RJ Hamster
RJ Hamster
Your free Stock Grader access is ready (plus something…
Dear reader,
Thank you for requesting access to my stock grading system.
Your 3 free stock searches are ready right now.
Click here to access your free stock grader.
Just type in any stock ticker symbol (AAPL, TSLA, NVDA, etc.) and you’ll see its current A-F grade based on my quantitative analysis.
Grade your current holdings. Check stocks you’re considering. Verify Check everything I’m about to tell you.
But before you do that, I need to share something urgent with you.
Something Strange is Happening
Those 3 free stock searches? They’ll help you evaluate individual stocks.
But they won’t show you what I’m seeing across the ENTIRE market right now.
And what I’m seeing should concern every investor in America.
Let me show you what I mean
Right now, Warren Buffett is holding $344 billion in cash—the largest cash position in his entire 60-year career.
At the exact same time, tech CEOs are selling their own companies:
- Jensen Huang dumping Nvidia shares
- Jeff Bezos selling billions in Amazon shares
- Mark Zuckerberg exiting some of his Meta positions
While CNBC tells YOU to buy.
Here’s my question: Why would the people who RUN the AI companies be selling… while the government is deploying $90 billion into AI infrastructure?
Something doesn’t add up.
And when I run my grading system across all 6,000 publicly traded stocks, I see something I’ve only seen twice before in my 40+ year career:
- In 1999.
- In 2008.
Both times, most investors thought they were in a bull market.
Both tines, they were wrong.
Both times, massive wealth transfers happened—from those who couldn’t see the pattern to those who could.
Click here to see the full $7 Trillion Wealth Transfer Presentation!
This is the most important presentation I’ve created in my 46-year career.
Because the wealth transfer is happening RIGHT NOW. Not next year. Not next month. Today.
And every day you wait is a day institutions are ahead of you.
Watch it now while you still have time to position correctly.
To your success,
Louis Navellier
P.S. – Don’t wait until the wealth transfer is obvious to everyone. By then, it’s too late. Watch the presenation now.
RJ Hamster
The $0.85 AI Layer Backed by Tech Insiders
Below please find a special message from one of our sponsors, RAD Intel. From time to time we find special opportunities we believe you as a valued customer may want to see. Please note that the following message reflects the opinions and representations of our sponsor alone, and not necessarily the opinion or editorial positions of Eagle Financial Publications or Salem Media.
Big Tech’s Billions Are Just the Beginning
Meta is spending $72 billion. Google says $93 billion. Microsoft is doubling down. AI infrastructure is now the centerpiece of global tech investment – and it’s not slowing down.
As the tech giants battle for dominance in AI, one truth is emerging: infrastructure is everything. And a lesser-known company – already serving Fortune 1000 brands with 7-figure recurring contracts – has carved out a critical piece of the puzzle.
RAD Intel powers the “AI decision layer” that helps marketing teams, data buyers, and media agencies extract performance from their campaigns. With 3.5X average ROI, RAD’s impact is measurable. It’s not a hype cycle – it’s operational tech with proven outcomes.
It’s no surprise that Google, Amazon and Meta insiders have backed the company. Nor is it surprising that RAD Intel has raised over $60 million, was selected by the Adobe Design Fund, and grown valuation 5,000% over the last 4 years.
The window is still open for everyday investors – but the share price already moved once. RAD Intel is now available at $0.85/share, and there’s a limited allocation remaining.
If you missed Nvidia… missed Palantir… don’t let this slip past you.
Discover the company quietly building the marketing engine behind AI’s trillion-dollar frontier.
*This valuation has been set by RAD Intel.
DISCLOSURE: This is a paid advertisement for RAD Intel’s made pursuant to Reg A+ offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radintel.ai.
To ensure future delivery of Eagle Financial Publication’s emails please add the domain @mail.eaglefinancialpublications.com to your address book or contact list.
This email was sent to pahovis@aol.com because you are subscribed to the Carefully Selected Financial Offers from Third Parties List. To unsubscribe please click here. To stop receiving emails simply click here. View this email in your web browser.
If you have questions, please send them to Customer Service.
Salem Media – Eagle Financial Publications | 1735 N Lynn St, Suite 500, Arlington, VA 22209-2016
© 2026
Eagle Financial Publications. All rights reserved.
RJ Hamster
Front and Center Friday: (NASDAQ: MTVA) Hits Our Radar
Front and Center Friday: (NASDAQ: MTVA) Hits Our Radar
— Read on market-maven-insights.beehiiv.com/p/front-and-center-friday-nasdaq-mtva-hits-our-radar-a4c2
RJ Hamster
Investing and Stock News – Stock Exchange Insiders Stock…
Stay ahead with the latest insights on crypto, economy, and investing. Get expert analysis, market trends, and smart strategies to guide your financial decisions.
— Read on stockexchangeinsiders.com/
RJ Hamster
10XProTrader Update: +106% Move
MIMI Rallies to a High of $.62
Running Up 57% in Gains
10XProTrader Member,
This is Kevin Vander with “10XProTrader” Saying Congrats on MIMI!
I alerted MIMI on February 9, premarket at approx. $.39, and it rocketed to a premarket high of $.62 today February 13, representing 57% in gains from my initial alert.
Take a look at the Snapshot of Level II below.
CHOW Rallies to a High of $1.38
Running Up 49% in Gains
I alerted CHOW on January 2, premarket at approx. $.92, and it rocketed to a high of $1.38 on Thursday February 12, running up +49% in gains from my initial alert.
Take a look at the Snapshot of Level II below.
If you liked your picks I’ve just listed above which soared up 106% in combined gains, you are going to love what I have in store for you next.
Kevin Vander
Chief Strategist, 10XProTrader
@ 2026 10XProTrader.. All Rights Reserved. You are receiving this e-mail as part of your subscription to 10XProTrader. Nothing in this email should be considered personalized fina·ncial advice. 10XProTrader is neither a registered inve·stment adviser nor a broker/dealer. Readers are advised that this electronic publication is issued solely for information purposes only and should not be construed as an offer to s·ell or the solicitation of an offer to b·uy any sec·urity. 10XProTrader is a fina·ncial publisher that does not offer any personal fina·ncial advice or advocate the p·urchase or s·ale of any sec·urity or inve·stment for any specific individual. This communication is note a sponsored adv·ertisement. We maintain zero positions in all profiled s·tocks and do not trade in any sec·urities we feature. We do not, under any circumstance, accept s·tock as c·ompensation for sponsored a·dvertising.
@ 2026 10XProTrader, 340 Royal Poinciana Way Suite 317, Palm Beach, FL 33480, United States of America
You may unsubscribe or change your contact details at any time.
RJ Hamster
NVIDIA Can’t Fix This Problem
The $15 trillion bottleneck between AI and reality…
— Read on moonshotminute.com/p/nvidia-can-t-fix-this-problem
RJ Hamster
Rich Future Stocks – Investment and Stock News
Rich Future Stocks – Investment and Stock News
— Read on richfuturestocks.com/
RJ Hamster
The Titanium Bottleneck the West Can’t Ignore
This is a paid advertisement. Full disclosures and risk factors are provided at the bottom of this email.
Dear Reader,
China controls much of the world’s titanium supply, leaving the West exposed to significant supply bottlenecks.
Saga Metals is advancing a titanium system in Labrador– where early drilling indicates the presence of a large mineralized system but in a far safer jurisdiction.
Thick oxide layers. Extreme magnetic readings. Road access, hydropower, and deepwater shipping nearby.
Now add this: Rio Tinto holds an option agreement with Saga on a separate lithium project in Quebec.
Such agreements reflect strategic interest, though no outcomes are implied.
Click here to see why Saga Metals is starting to draw attention.
-The Capital Trends Team
THIS IS A PAID ADVERTISEMENT
This communication is a paid advertisement and is not a recommendation to buy or sell securities. The advertiser, Think Ink Marketing, acting on behalf of Saga Metals, has paid Darwin Investor Network $8,000 to distribute this advertisement.
Neither the advertiser nor Darwin Investor Network owns or has any agreement to receive shares or other securities of Saga Metals in connection with this promotion.
Investing in small-cap, microcap, or penny stocks involves significant risks, including the loss of principal. These securities are highly volatile, illiquid, and subject to sudden price changes. Past performance is not indicative of future results.
This information is based on publicly available sources and has not been independently verified. Investors should conduct their own due diligence and rely on official company filings.
The promoted company, its affiliates, or third-party shareholders may sell shares during or after the promotion, which could negatively impact share prices. Companies highlighted in promotional campaigns often experience significant fluctuations in stock price and trading volume.
Darwin Investor Network is not registered or licensed as a financial advisor, broker, or investment professional. We do not provide financial, investment, or trading advice.
Misleading statements in stock promotions may constitute securities fraud under U.S. and Canadian law. Investors should rely only on official regulatory filings before making investment decisions.
This communication may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to risks and uncertainties described in the Company’s SEC filings.
For official filings and investor disclosures, visit:
- Saga Metal’s SEDAR+ Filings
- Saga Metal’s Investor Relations Page
- Saga Metal’s Full Disclaimer and Disclosures
By accessing this information, you acknowledge and agree that Darwin Investor Network, its affiliates, owners, and representatives are not liable for any financial or investment decisions based on this communication.Advertising Disclosure: This email contains paid advertisements. This email is from our associates at Capital Trends.
Legal Entity Information: Investing Ideas Daily is owned and operated by Darwin Investor Network, a DBA of The Darwin Agency, Inc.
Disclaimer: Nothing in this email should be considered personalized financial advice. Always conduct your own due diligence when investing. We urge you to read our full disclaimer by clicking on the terms of use link below.
Unsubscribe: You are receiving this email as part of your complimentary subscription to the Investing Ideas Daily E-Letter. If you would like to unsubscribe, you can do so by clicking on the unsubscribe link below.Darwin Investor Network
2319 N Andrews Avenue, Fort Lauderdale, FL 33311
support@investingideasdaily.com | 1-800-496-9838Investing Ideas Daily | Privacy Policy | Terms of Use
Unsubscribe | View Online
RJ Hamster
HCTI – New NASDAQ Alert
*Read Disclaimer Sponsored Content
February 13, 2026 | Unsubscribe
Hello!
New Alert: Healthcare Triangle, Inc. (Nasdaq: HCTI)
HCTI is our new NASDAQ high volatility alert.
HCTI has a history of experiencing significant volatility in a very short period of time.
As of yesterday’s close, HCTI has massively diverged from its 20- and 50-day moving averages.
HCTI has a 20 day moving average of 16.44, +127% above yesterday’s close.
The chart setup alone is pointing to a massive breakout opportunity.
HCTI is a NASDAQ listed “leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries”
HCTI “based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise”.
The company supports “healthcare organizations including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on”.
HCTI “achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security”.
HCTI “enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats”.
The highly regulated healthcare and life sciences industries rely on HCTI for “expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical & business performance optimization”.
Here are some of the company’s recent big accomplishments.
In October, the company announced:
“Healthcare Triangle Subsidiary QuantumNexis Reports $20M in Consumption-Based Revenue Processed on Ezovion Platform, Forecasts $37M Amid Rapid Growth”
Here are some of the highlights:
- “QuantumNexis’s Ezovion Electronic Medical Record (EMR) platform has processed over $20 million in revenue generated by healthcare providers who rely on the platform to digitize and manage their operations.”
- “This milestone underscores Ezovion’s expanding role as the digital infrastructure powering hospitals, clinics, and specialty care providers across multiple markets, enabling seamless digitization, streamlined workflows, and improved patient outcomes.”
- “As QuantumNexis accelerates its global expansion into India, Bangladesh, Saudi Arabia, and Malaysia, the total revenue processed through the platform by end users is projected to surge from $20 million to $37 million over the next six months. This growth reflects both rapid adoption by new customers and deeper engagement by existing healthcare providers who are expanding their digital footprints.”
Strategic Impact for Shareholders
“The QuantumNexis milestone and payment gateway launch create multiple value growth drivers for HCTI”:
- “$20M+ in end-user revenue already processed through the Ezovion platform, demonstrating strong market traction and platform adoption.”
- “Projected growth to $37M in end-user revenue within six months, driven by aggressive international expansion and deeping customer engagement with existing customers.”
- “Launch of an integrated payment gateway to directly monetize transaction flows, transforming platform activity into predictable recurring revenue for HCTI.”
- “Strategic positioning as a hybrid SaaS + fintech company, creating a differentiated investment thesis that appeals to both healthcare technology and fintech-focused institutional investors.”
- “Initial payment gateway deployments planned for late 2025, with comprehensive global scaling throughout 2026.”
David Ayanoglou, Chief Financial Officer of Healthcare Triangle Inc, concluded,
“The rapid increase in end-user revenue processed through Ezovion reflects strong adoption and engagement by healthcare providers. By launching our payment gateway, HCTI can transform this activity into direct, recurring revenue while driving margin expansion and delivering long-term shareholder value.”
In October, the company also announced:
“Healthcare Triangle Takes Bold Step toward AI-Driven Future with the Signing of a Non-Binding LOI for the Acquisition of Teyame.AI, which is on track to generate $34M in Revenue for fiscal year 2025 and would create for Healthcare Triangle a Next-Generation Global Customer Engagement Platform”
The strategic acquisition would address a critical gap in healthcare: the disconnect between advanced clinical systems and meaningful patient interaction.
By combining HCTI‘s “deep healthcare technology expertise with Teyame’s proven AI automation customer engagement platform, an integrated ecosystem would be created where every patient touchpoint would become intelligent, personalized, and outcome-focused”.
“Based on financial information the Company has received from Teyame, the Company expects Teyame to generate approximately $34 million in incremental annual revenue and $4.2 million in incremental EBITDA for fiscal year 2025.”
The acquisition could “represent a pivotal moment in HCTI’s evolution from healthcare IT provider to comprehensive digital health innovator and could significantly enhance HCTI’s financial performance and shareholder value”.
Here are some of the company’s comments:
“The transaction would bring real world lived experience of Agentic Gen AI, in addition to material revenues and profitability to HCTI” added David Ayanoglou, Chief Financial Officer of HCTI”
Proven AI Innovation and Customer Engagement Meets Healthcare Expertise
Madrid-headquartered Teyame.AI has built a “sophisticated platform that seamlessly blends artificial intelligence with human expertise, currently serving banking and insurance clients while piloting breakthrough healthcare applications”.
The company’s “technology stack includes advanced chatbot automation, multilingual patient engagement tools, and real-time analytics… capabilities that become exponentially more powerful when integrated with HCTI’s clinical systems.”
Key highlights of Teyame’s innovation include:
- “Integration of Agentic Generative AI (Gen AI) into core operations.”
- “Advanced AI-human collaboration models to drive efficiency.”
- “Pilots of AI-powered healthcare services, such as appointment confirmations and multilingual patient engagement.”
- “Evolution into a digital-first, AI-powered global CX provider.”
Building a Comprehensive Healthcare Engagement Platform
Once completed, this acquisition would create a “global, digital-first patient engagement platform that combines HCTI’s healthcare technology expertise with Teyame’s advanced automation capabilities”.
Key anticipated synergies include:
- “Integration with QuantumNexis (HCTI Subsidiary) Products”
- “Teyame’s omnichannel platform will seamlessly integrate with Ziloy, QuantumNexis’ advanced AI engine, and Ezovion, a comprehensive EHR/HIS solution.”
- “This combination will deliver a front-end, patient engagement platform tightly connected to back-end clinical systems.”
- “Enhanced Patient Engagement”:
- “Expansion of Ziloy’s digital mental health programs using chatbot-led, AI-driven workflows.”
- “Personalized care journeys and outreach based on real-time patient data.”
- “Global Market Reach”:
- “Expansion into Europe, Latin America, Middle East and Asia-Pacific leveraging Teyame’s multilingual, scalable platform.”
- “AI-Driven Personalization”:
- “Intelligent automation for treatment plans, chronic care workflows, and targeted outreach, improving patient outcomes and hospital efficiency.”
- “Cross-Selling Opportunities”:
- “Immediate ability to introduce Teyame’s capabilities to HCTI’s extensive hospital and clinic network.”
- “Acquisition of High-Quality Talent”:
- “Strengthening HCTI’s innovation team with Teyame’s domain experts in AI, CX, and automation.”
As the company further notes:
“This strategic acquisition would expand our reach into international markets and provide our customers with cutting-edge Gen AI solutions,” said Sujatha Ramesh, Chief Operating Officer of HCTI. “By integrating Teyame’s technology and services with HCTI’s healthcare offerings, we could create a next-generation, AI-powered ecosystem for patients, providers, and healthcare organizations.”
Strategic Growth Alignment
This LOI could be a critical step in HCTI’s broader strategy focused on:
- “AI-driven healthcare innovation.”
- “Global SaaS platforms for patient engagement and care management.”
- “Expansion into high-growth international markets through digital-first healthcare solutions.”
By uniting human expertise with advanced AI, HCTI is “accelerating its transformation into a global healthcare technology leader, creating measurable impact for patients, providers, and shareholders”.
In December, the company followed up with this announcement:
- “Healthcare Triangle, Inc. Signs Advance Agreement for the Acquisition of Next-Generation AI Customer Engagement Business, on track to generate $34M in Revenue for FY 2025”
In January, the company announced:
“Healthcare Triangle, Inc. Signs Definitive Agreement with Teyame AI LLC which is forecasted to generate $38M in incremental NTM Revenue and incremental NTM EBITDA of $5M in addition to expanding its SaaS Footprint in Europe and Latin America”
Here are the comments from this press release:
“The transaction will bring real world lived experience of Agentic Gen AI and is about to change the game for HCTI. It’s where the rubber meets the road in AI” added David Ayanoglou, Chief Financial Officer of HCTI.
‘We are pleased to take this decisive step with the signing of the Definitive agreement. Integrating these AI-powered engagement platforms with HCTI’s healthcare technologies positions us to deliver a next-generation, intelligent ecosystem for patients, providers, and expanding SaaS Footprint into Europe and Latin America.”— Sujatha Ramesh, Chief Operating Officer, Principal Executive Officer, and Director, Board of Directors, HCTI.
Most recently, the company announced:
“Healthcare Triangle Inc. Partners with Better.care to Expand Health Data Platform Services Across EMEA’s Leading Healthcare Systems”
- “Partnership positions Healthcare Triangle as preferred service provider across high-growth healthcare markets in Europe, Southeast Asia, Middle East, and Africa”
Key Highlights of the Collaboration
- “Workforce Enablement:
Launch of structured training and certification programs for teams across HCTI and its wholly owned subsidiary QuantumNexisInc. to accelerate the adoption of Better’s solutions. - Global Market Growth:
- Southeast Asia: Joint focus on opportunities in India, Malaysia, as well as Indonesia and the Philippines.
- Middle East & Africa: Expansion plans targeting Saudi Arabia and multiple African markets, with HCTI positioned as a preferred service partner for Better.”
Here are some of the company’s comments from this press release:
“This collaboration reflects our shared vision of transforming healthcare delivery globally,” said Suresh Venkatachari, Chairman of QuantumNexis.
“By combining Healthcare Triangle and its subsidiary QuantumNexis’ innovation and execution capabilities with the robust Better platform, we are uniquely positioned to bring cutting-edge digital health solutions to emerging markets and make a meaningful impact on patient care.”
In addition:
“We are thrilled to welcome Healthcare Triangle and QuantumNexis into our Partner Development Programme and to collaborate on advancing openEHR adoption,” said Petar Abadžić, International Markets Director at Better.
“With healthcare systems rapidly evolving, this partnership demonstrates how open data standards and modern platform technology can enable innovation at scale. We aim to support healthcare providers in building systems that are interoperable, future-proof, and focused on patient outcomes,” he added.
In addition, last week, the company announced:
“Healthcare Triangle Inc. subsidiary QuantumNexis Announce Joint Venture with Golden Code Holdings to Accelerate AI and Digital Health Transformation in Saudi Arabia”
- “This Joint Venture strengthens Healthcare Triangle’s and QuantumNexis’ position to access the fastest growing Saudi Arabia 70-billion-dollar Healthcare Market by 2030”
“This Joint Venture brings together QuantumNexis’ global expertise in AI‑powered healthcare platforms and open standards with Golden Code Holdings’ strong local presence, investment capability, and deep understanding of the Saudi market. It will play a pivotal role in supporting Saudi Vision 2030, the Ministry of Health’s digital strategy, and the Kingdom’s ambition to build a world‑leading, interoperable, and data‑driven healthcare ecosystem and shifting towards value-based care, focusing on patient outcomes rather than volume.”
Driving National‑Scale Digital Health Modernization
The QuantumNexis Team will introduce a unified suite of advanced digital health platforms in Saudi Arabia, including:
- Ezovion — a next‑generation hospital and clinical operations platform
- Ziloy.ai — AI‑powered clinical and operational intelligence
- Readabl.ai — automation and documentation intelligence for care teams
- openEHR ‑ based interoperability solutions through global partnerships with Better.care and Microsoft.
These solutions will support hospitals, clinics, and enterprise healthcare groups in modernizing workflows, improving care coordination, and enabling real‑time insights across the continuum of care.
Aligned with Saudi Arabia’s Vision 2030
The Joint Venture is designed to advance key national priorities by:
- Deploying open standards and interoperable platforms across health systems
- Enabling AI‑driven decision support, predictive analytics, and operational optimization
- Building a Saudi‑based digital health workforce through capability development programs
- Supporting localization, compliance, and long‑term sustainability
- Establishing a regional hub for innovation, research, and co‑development
HCTI could be positioned for a big breakout higher.
Make sure to do your own due diligence.
Sources: PR1, PR2, PR3, PR4, PR5, PR6, PR7, PR8, Website, Chart
Happy Trading!
SmallCapStocks Team
Note: We encourage all traders and investors to develop personal trading rules that you can follow and that work for you. Always protect your downside and note that we alert extremely volatile short-term opportunities. Before investing in securities, you should always consult with your financial, tax and legal advisor and never invest money you cannot afford to lose.
DISCLAIMER:
You should read and understand this disclaimer in its entirety before joining the website or email/blog list of SmallCapStocks.com (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.
The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the “SEC”) at www.sec.gov; the Financial Industry Regulatory Authority (the “FINRA”) at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.gov/consumer/cyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.
The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.
Owners and operators of the Publisher have been compensated nine thousand dollars by bank wire transfer on 1/30/26 for the distribution of this advertisement about HCTI dated 2/13/26. Previously, owners and operators of the Publisher have been compensated eight thousand dollars by bank wire transfer on 1/12/26 for the distribution of a prior advertisement about HCTI. Previously, owners and operators of the Publisher have been compensated eight thousand dollars by bank wire transfer on 12/9/25 for the distribution of a prior advertisement about HCTI. Previously, owners and operators of the Publisher have been compensated eight thousand dollars by bank wire transfer on 10/16/25 for the distribution of a prior advertisement about HCTI. Prior to the past year, at the time of publication, we disclosed our compensation for the distribution of advertisements about HCTI. The Publisher and its owners and operators hold no stocks or bonds in companies discussed in the Advertisement. Owners and operators of the Publisher own several newsletters, therefore you may receive multiple publications and emails featuring companies at different or the same time.
You are receiving this report/release because you subscribed to receive it at our website or through a third-party site. All our newsletters include an “unsubscribe” link, and you can remove yourself at any time from our newsletters by clicking on that “unsubscribe” link. You can also contact us at info@SmallCapStocks.com to change your information at any time. By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link:
www.SmallCapStocks.com/Disclaimer and www.SmallCapStocks.com/Privacy-Policy
By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.
Update your email preferences or unsubscribe here
© 2026 Small Cap Stocks
1969 South Alafaya Trail
Orlando, Florida 32828, United StatesPowered by beehiivTerms of Service